ABG
Ally Bridge Group Portfolio holdings
AUM
$114M
This Quarter Return
+2.67%
1 Year Return
+41.64%
3 Year Return
+246.39%
5 Year Return
–
10 Year Return
–
AUM
$356M
AUM Growth
+$356M
(-14%)
Cap. Flow
-$43.3M
Cap. Flow
% of AUM
-12.14%
Top 10 Holdings %
Top 10 Hldgs %
56.65%
Holding
39
New
7
Increased
5
Reduced
6
Closed
11
Top Buys
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$15.3M |
| 2 |
Nautilus Biotechnolgy
NAUT
|
$15.2M |
| 3 |
CYT
Cyteir Therapeutics, Inc. Common Stock
CYT
|
$13.4M |
| 4 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$12M |
| 5 |
Arvinas
ARVN
|
$10.5M |
Top Sells
| 1 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
$27M |
| 2 |
Intellia Therapeutics
NTLA
|
$21.4M |
| 3 |
Atea Pharmaceuticals
AVIR
|
$11.4M |
| 4 |
ITOS
iTeos Therapeutics
ITOS
|
$11M |
| 5 |
Oric Pharmaceuticals
ORIC
|
$10.1M |
Sector Composition
| 1 | Healthcare | 97.16% |
